Physiatry Sharing Session 4: Efficacy of Omaveloxolone in Friedreich’s Ataxia: Delayed-Start Analysis of the MOXIe Extension

Canadian Neuromuscular Community of Practice

Session Chair:  Dr. Marianne Nury Topic: Friedreich’s Ataxia and the newly FDA-approved drug Omaveloxolone, based on the article “Efficacy of Omaveloxolone in Friedreich’s Ataxia: Delayed-Start Analysis of the MOXIe Extension” by Lynch et al., 2022. Discussion: The event will take place on Tuesday, November 12th at 7pm ET/4pm PT/8pm AT/6pm MT. If you are interested in attending, please…

Read More